[1] D J PORTER. Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil.[J]. The Journal of Biological Chemistry, 1992, 267 8: 5236-5242.
[2] D P BACCANARI. 5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1993, 90 23: 11064-11068. DOI:
10.1073/pnas.90.23.11064[3] R L SCHILSKY H L K. Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.[J]. Expert opinion on investigational drugs, 2000, 9 7: 1635-1649. DOI:
10.1517/13543784.9.7.1635